SMNR
Semnur Pharmaceuticals, Inc.Company with tickers: SMNR, SMNRW
CIK
1913577
CUSIP
81686G105
Shares Outstanding
230,209,142
Website
https://www.semnurpharma.com
Investor Relations
https://semnurpharma.com/investor-overview/
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2023-08-15 | 2023-06-30 | |
| 8-K | 2023-08-04 | — | |
| 8-K | 2023-07-13 | — | |
| 10-Q | 2023-05-15 | 2023-03-31 | |
| 8-K | 2023-04-12 | 2023-04-11 | |
| 10-K | 2023-03-17 | 2022-12-31 | |
| 8-K/A | 2023-01-26 | 2023-01-25 | |
| 8-K | 2023-01-26 | 2023-01-25 | |
| 10-Q | 2022-11-16 | 2022-09-30 | |
| 8-K | 2022-10-19 | 2022-10-14 | |
| 10-Q | 2022-08-12 | 2022-06-30 | |
| 8-K | 2022-05-27 | 2022-05-26 | |
| 10-Q | 2022-05-23 | 2022-03-31 | |
| 8-K | 2022-04-15 | 2022-04-11 | |
| 8-K | 2022-04-12 | 2022-04-06 |
Showing 51–65 of 65 filings